Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Posthouwer, D
Right arrow Articles by Mauser-Bunschoten, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Posthouwer, D
Right arrow Articles by Mauser-Bunschoten, E.
Haematologica, Vol 90, Issue 6, 846-850
Copyright © 2005 by Ferrata Storti Foundation

Journal Article

Hepatitis C and health-related quality of life among patients with hemophilia

D Posthouwer, I Plug, JG van der Bom, K Fischer, FR Rosendaal, and EP Mauser-Bunschoten

Van Creveldkliniek, University Medical Center Utrecht, Heidelberglaan 100, C.01.425, 3508 GA, Utrecht, The Netherlands. D.Posthouwer@azu.nl

Hepatitis C has a negative effect on health-related quality of life (HRQoL). It is not clear whether hepatitis C affects HRQoL of patients with hemophilia. The objective of this study was to assess the effect of hepatitis C virus (HCV) infection on HRQoL in patients with hemophilia. A cross-sectional study was performed among all registered hemophilia patients in the Netherlands. HRQoL was determined by using the self-administered SF-36 questionnaire. Patients were eligible for the study if they completed the SF-36, had been treated with clotting factor products before 1992, and had reported their hepatitis C status. Data on the severity of hemophilia were obtained from the hemophilia treatment centers. The validity of the self-reported data on hepatitis C status was verified in a random sample of 92 (15%) patients; 92% reported their hepatitis C status correctly. Fifty-five percent (333/602) of the study population had a current HCV infection. All eight domains of the SF-36 were lower in patients with a current HCV infection than they were in patients who had never been infected with HCV. After adjustment for age, severity of hemophilia, human immunodeficiency virus (HIV) status, employment status, and joint limitations, hepatitis C infection was associated with a decrease of HRQoL on the domains of general health (difference 6.9 [95% confidence interval (C.I.) 2.7 to 11.2]) and vitality (3.8 [95% C.I. 0.1 to 7.7]). Hemophilia patients infected with HCV scored lower on the HRQoL domains of general health and vitality than hemophilia patients who had never been infected with HCV.


This article has been cited by other articles:


Home page
 BloodHome page
I. Plug, M. Peters, E. P. Mauser-Bunschoten, A. de Goede-Bolder, L. Heijnen, C. Smit, J. Willemse, F. R. Rosendaal, and J. G. van der Bom
Social participation of patients with hemophilia in the Netherlands
Blood, February 15, 2008; 111(4): 1811 - 1815.
[Abstract] [Full Text] [PDF]

Home page
 Clin TrialsHome page
K. F. Murray, J. R. Rodrigue, R. P. Gonzalez-Peralta, J. Shepherd, B. A. Barton, P. R. Robuck, K. B. Schwarz, and for the PEDS-C Clinical Research Network
Design of the PEDS-C trial: pegylated interferon +/- ribavirin for children with chronic hepatitis C viral infection
Clinical Trials, December 1, 2007; 4(6): 661 - 673.
[Abstract] [PDF]


HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2005 by the Ferrata Storti Foundation.